Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.9% sodium chloride1件: Sodium chloride1件: Sodium chloride 💬 --5件: 6, 14, 51, 53, 96 💬
210% intravenous immunoglobulin (IVIg)----1件: 14 💬
310% liquid formulation of human immunoglobulin----1件: 14 💬
4: immunoglobulina umana normale 10% per somministrazione endovenosa----1件: 14 💬
5[ARGX-117 IV]----1件: 14 💬
6[BIVV020]----1件: 14 💬
7[Clorfenamina maleato]----1件: 14 💬
8[J07AH07]----1件: 14 💬
9[Metilprednisolone sodio succinato]----2件: 14, 66 💬
10[NA]----34件: 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
11[non fornito]----1件: 14 💬
12[Paracetamolo]----4件: 14, 19, 300, 309 💬
13[rituximab]1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 11, 14 💬
14Act-HiB----3件: 14, 62, 223 💬
15Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14 💬
16ALEMTUZUMAB1件: Alemtuzumab1件: Alemtuzumab 💬 --21件: 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
17Alemtuzumab infusion1件: Alemtuzumab1件: Alemtuzumab 💬 --1件: 14 💬
18Anti-C5 antibody----4件: 11, 14, 62, 109 💬
19Anti-Thymocyte Globulin----19件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
20ARGX-113----5件: 11, 14, 35, 53, 63 💬
21ARGX-117----1件: 14 💬
22ARGX-117 IV----1件: 14 💬
23Autologous Hematopoietic Stem Cell Transplantation----7件: 11, 13, 14, 28, 49, 51, 84 💬
24BAFF-R CART----2件: 11, 14 💬
25Batoclimab1件: Batoclimab1件: Batoclimab 💬 --2件: 11, 14 💬
26Batoclimab 340 mg SC weekly1件: Batoclimab1件: Batoclimab 💬 --2件: 11, 14 💬
27Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly1件: Batoclimab1件: Batoclimab 💬 --1件: 14 💬
28Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)----1件: 14 💬
29Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)----1件: 14 💬
30BIOTIN1件: Biotin1件: Biotin 💬 --6件: 2, 8, 10, 13, 14, 20 💬
31BIVV020----3件: 14, 61, 63 💬
32Blood sample----33件: 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
33Blood sampling----15件: 2, 3, 13, 14, 17, 46, 51, 64, 86, 96, 97, 98, 106, 162, 300 💬
34Carmustine1件: Carmustine1件: Carmustine 💬 --5件: 11, 13, 14, 28, 60 💬
35CD19/BCMA-targeted CAR-T cells----3件: 11, 13, 14 💬
36CLAIRYG 50 mg/ml----1件: 14 💬
37CLAIRYG 50mg/ml----1件: 14 💬
38Claseprubart1件: Claseprubart---2件: 11, 14 💬
39CLORFENAMINA MALEATO----1件: 14 💬
40Conventional Therapy----5件: 14, 49, 67, 97, 222 💬
41CT103A1件: CT103A---4件: 11, 13, 14, 16 💬
42CT103A cells1件: CT103A---4件: 11, 13, 14, 16 💬
43Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
44Cyclophosphamide and fludarabine2件: Cyclophosphamide,
Fludarabine		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬4件: 11, 13, 14, 16 💬
45Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
46Cytarabine1件: Cytarabine2件: Cytarabine ,
Cytarabine hydrochloride 💬 		--8件: 11, 13, 14, 25, 34, 49, 60, 65 💬
47D-BIOTIN1件: Biotin1件: Biotin 💬 --4件: 10, 13, 14, 20 💬
48Dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬29件: 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
49Diagnostic Test: NT3 blood draw----2件: 10, 14 💬
50ECULIZUMAB1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 11, 13, 14, 61, 62, 109, 221, 223 💬
51Efgartigimod1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --8件: 11, 14, 35, 36, 53, 63, 64, 300 💬
52EFGARTIGIMOD ALFA1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --7件: 11, 13, 14, 35, 53, 63, 162 💬
53Efgartigimod PH20 SC1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --7件: 11, 14, 35, 50, 53, 63, 162 💬
54Efgartigimod PH20 SC in stage B----1件: 14 💬
55Empasiprubart1件: Empasiprubart1件: Empasiprubart 💬 1件: C2 💬 6件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 11, 14, 50 💬
56Empasiprubart IV1件: Empasiprubart1件: Empasiprubart 💬 1件: C2 💬 6件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 11, 14, 50 💬
57Etoposide1件: Etoposide2件: Etoposide ,
Etoposide phosphate 💬 		--12件: 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
58FAMPRIDINE----2件: 13, 14 💬
59FAMPYRA----2件: 13, 14 💬
60Fibrinogen concentrate----1件: 14 💬
61FINGOLIMOD1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
62FINGOLIMOD HYDROCHLORIDE1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
63Fludarabine1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
64FTY720I----1件: 14 💬
65Gammanorm----2件: 14, 65 💬
66Gamunex-C----2件: 14, 65 💬
67Genetic: Genome-wide association study----1件: 14 💬
68Gilenya----3件: 2, 13, 14 💬
69GILENYA 0,5 mg cápsulas duras----1件: 14 💬
70Group C meningococcal conjugate vaccine----1件: 14 💬
71H.P. Acthar® Gel----1件: 14 💬
72HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)----2件: 13, 14 💬
73Haemophilus type b vaccine (conjugated)----1件: 14 💬
74HB-adMSCs----8件: 2, 4, 6, 13, 14, 46, 49, 113 💬
75HBM9161----1件: 14 💬
76Hematopoietic Stem Cell Transplantation----13件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
77Hidrocloruro de fingolimod1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
78Himan Normal Immunoglobulin----1件: 14 💬
79Hizentra----4件: 14, 50, 51, 65 💬
80Hizentra®----2件: 14, 65 💬
81HL161BKN----1件: 14 💬
82HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G1件: Globulin, immune 💬 --4件: 14, 50, 63, 65 💬
83Human normal 10% immunoglobulin for intravenous administration----1件: 14 💬
84Human normal 10% immunoglobulin for intravenous administrationn----1件: 14 💬
85Human normal immunoglobulin----6件: 13, 14, 50, 51, 63, 65 💬
86HUMAN NORMAL IMMUNOGLOBULIN (IV)----4件: 11, 14, 63, 65 💬
87Human normal immunoglobulin (IVIg)----3件: 14, 50, 65 💬
88Human normal immunoglobulin (SCIg)----1件: 14 💬
89Human normal immunoglobulin for intravenous administration----3件: 14, 51, 65 💬
90Human normal immunoglobulin G (IgG > 98% purity)----3件: 14, 63, 65 💬
91Hyaluronidase1件: Hyaluronidase3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--7件: 13, 14, 28, 51, 60, 65, 331 💬
92HYQVIA----2件: 14, 65 💬
93HYQVIA - 100 MG/ML - SOLUZIONE PER INFUSIONE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 300 ML E FLACONCINO (VETRO) 15 ML - 1 FLACONCINO + 1 FLACONCINO----1件: 14 💬
94HyQvia 100 mg/ml solution for infusion for subcutaneous use----2件: 14, 65 💬
95I10----1件: 14 💬
96I10E----3件: 14, 63, 65 💬
97IGIV GAMMAGARD LIQUID/KIOVIG----1件: 14 💬
98IGIV GAMUNEX®-C----1件: 14 💬
99IGIV, 10%----2件: 14, 65 💬
100IgPro10----4件: 14, 51, 63, 65 💬
101IgPro20----4件: 14, 50, 51, 65 💬
102IgPro20 (high dose)----1件: 14 💬
103IgPro20 (low dose)----1件: 14 💬
104IGVENA*FL 200ML 10G+SET----2件: 14, 50 💬
105Imeroprubart----1件: 14 💬
106Immune globulin----3件: 11, 13, 14 💬
107Immune globulin (human) 10% solution for intravenous administration----1件: 14 💬
108Immune Globulin 10% Intravenous Solution----1件: 14 💬
109Immune Globulin Intravenous (human), 10%----3件: 14, 63, 65 💬
110Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified----1件: 14 💬
111Immune Globulin Subcutaneous (Human)----2件: 14, 65 💬
112Immunoadsorption----2件: 13, 14 💬
113Immunoglobulin----3件: 13, 14, 63 💬
114IMMUNOGLOBULIN G----9件: 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
115Immunoglobulin perfusion----1件: 14 💬
116Immunoglobulina normale umana----2件: 14, 51 💬
117IMMUNOGLOBULINA UMANA NORMALE----4件: 14, 51, 63, 65 💬
118IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa----1件: 14 💬
119Immunoglobuline G----1件: 14 💬
120Immunoglobuline humaine normale----1件: 14 💬
121Immunoglobulins----1件: 14 💬
122Immunoglobulins, normal human, for extravascular adm.----1件: 14 💬
123Immunoglobulins, normal human, for intravascular adm.----2件: 14, 15 💬
124IMVT-1401----2件: 11, 14 💬
125INTERFERON BETA-1A2件: Human interferon beta,
Interferon beta-1a		2件: Interferon beta ,
Interferon beta-1a 💬 		2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬5件: 13, 14, 26, 96, 97 💬
126Intratect----4件: 13, 14, 35, 65 💬
127Intravenous gammaglobulin----1件: 14 💬
128Intravenous immune globulin G----1件: 14 💬
129Intravenous Immunoglobulin----9件: 13, 14, 35, 38, 39, 49, 51, 63, 309 💬
130Intravenous immunoglobulin (IVIg)----8件: 14, 17, 19, 63, 65, 85, 164, 296 💬
131IQYMUNE----1件: 14 💬
132IVIG----8件: 11, 13, 14, 18, 51, 63, 65, 172 💬
133IVIG (Intravenous Immunoglobulin)----2件: 11, 14 💬
134JNJ-80202135----5件: 11, 14, 46, 49, 53 💬
135KINE-101----1件: 14 💬
136KIOVIG----2件: 14, 65 💬
137KIOVIG - 100 MG/ML SOLUZIONE PER INFUSIONE USO INTRAVENOSO FLACONE VETRO 1 G/10 ML 1 FLACONE----1件: 14 💬
138KIOVIG 100 mg/ml solution for infusion----2件: 14, 65 💬
139KITE-363----5件: 11, 13, 14, 49, 51 💬
140Lipoic acid1件: Lipoic acid1件: Thioctic acid 💬 --6件: 2, 5, 13, 14, 20, 97 💬
141Lumbar puncture----9件: 2, 6, 13, 14, 19, 96, 97, 127, 201 💬
142Lymphodepleting Conditioning----3件: 11, 13, 14 💬
143M281/JNJ-80202135----1件: 14 💬
144MABTHERA - 1 FIALA 500 MG 50 ML----3件: 14, 53, 222 💬
145MAXTREX TABLETS----1件: 14 💬
146MD1003----5件: 2, 10, 13, 14, 20 💬
147Melphalan1件: Melphalan2件: Melphalan ,
Melphalan hydrochloride 💬 		--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
148Menjugate----1件: 14 💬
149Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
150Methotrexate ph. Eur.1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR2 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 14 💬
151Methylprednisolon (Solu-Medrol)1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 14 💬
152Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
153Methylprednisolone (Solu-Medrol)1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 14 💬
154Metilprednisolone sodio succinato----4件: 13, 14, 56, 66 💬
155N. MENINGITIDIS GROUP C POLYSACCHARIDE----1件: 14 💬
156NewGam----3件: 14, 63, 65 💬
157NewGam 10%----1件: 14 💬
158Nipocalimab1件: Nipocalimab1件: Nipocalimab 💬 --6件: 11, 14, 46, 49, 53, 61 💬
159NPB-01----3件: 13, 14, 162 💬
160NVG-2089----2件: 14, 63 💬
161Other: Fresh Frozen Plasma----1件: 14 💬
162Other: Laboratory Biomarker Analysis----22件: 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
163PANZYGA----2件: 14, 63 💬
164PARACETAMOLO----10件: 2, 11, 14, 19, 28, 53, 61, 63, 300, 309 💬
165Peripheral Blood Stem Cell Transplantation----12件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
166PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----2件: 13, 14 💬
167PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
168Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬58件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
169Prevenar 13 sospensione per iniezione----1件: 14 💬
170PRIVIGEN----6件: 11, 14, 51, 63, 65, 222 💬
171Privigen®----3件: 14, 63, 65 💬
172RHuPH20----2件: 13, 14 💬
173Riliprubart1件: Riliprubart1件: Riliprubart 💬 1件: C1S 💬 5件: Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 14 💬
174Riliprubart Prefilled Pen (PFP)1件: Riliprubart1件: Riliprubart 💬 1件: C1S 💬 5件: Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 14 💬
175Ripertamab1件: Ripertamab---4件: 11, 14, 63, 222 💬
176RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
177Rituximab (genetical recombination)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 14, 222, 223 💬
178Rituximab (Mabthera)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 14, 63 💬
179ROZANOLIXIZUMAB1件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
180RVG 51680----1件: 14 💬
181RVG 56083----1件: 14 💬
182RVT-1401----3件: 11, 14, 61 💬
183SAR445088----2件: 14, 61 💬
184SAR445088 (formerly BIVV020)----1件: 14 💬
185SAR445088 (IV)----1件: 14 💬
186SAR445088 (SC)----1件: 14 💬
187SC Investigational Needle Sets----2件: 14, 65 💬
188Sodium chloride1件: Sodium chloride1件: Sodium chloride 💬 --31件: 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
189Sodium Chloride 0.9%1件: Sodium chloride1件: Sodium chloride 💬 --2件: 14, 227 💬
190SOLIRIS----6件: 11, 13, 14, 62, 109, 223 💬
191SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----3件: 13, 14, 53 💬
192Subcutaneous immune globulin G----1件: 14 💬
193Subcutaneous immunoglobulin----1件: 14 💬
194Subcuvia----3件: 14, 49, 65 💬
195Syngeneic Bone Marrow Transplantation----3件: 11, 13, 14 💬
196TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE----1件: 14 💬
197TAK-411----1件: 14 💬
198TAK-771----2件: 14, 65 💬
199TAK-881----2件: 14, 65 💬
200TEGELINE 50mg/ml----1件: 14 💬
201Telitacicept1件: Telitacicept---14件: 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
202TRIMETON - 10 MG/1 ML SOLUZIONE INIETTABILE 5 FIALE 1 ML----1件: 14 💬
203Tégéline----1件: 14 💬
204UCAR T-cell----7件: 11, 13, 14, 49, 51, 66, 222 💬
205UCB76651件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
206Universal BCMA CAR-T----3件: 11, 13, 14 💬
207Universal CD19 CAR-?dT Cell Injection----3件: 11, 13, 14 💬
208Universal CD19 CAR-T----3件: 11, 13, 14 💬
209VACCINO PNEUMOCOCCICO SACCARIDICO----1件: 14 💬
210Vivaglobin----2件: 14, 65 💬
211Xembify----1件: 14 💬